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Why Nanoparticles?
• Nanoparticles can be the right tool for the job
• Advantages
– Enhanced bioavailability and controlled release
– Penetration across biological barriers
– Increased drug targeting efficiency









– Nanoparticles formed using monomers as the starting point
– Nanoparticles prepared using preformed polymers as the starting 
point
Methods Employing Preformed Polymers
• Emulsion Diffusion 
– Interfacial Precipitation
• Emulsion Evaporation 
– Double Emulsion Evaporation
• Salting Out
• Solvent Displacement 
– Nanoprecipitation, Solvent Diffusion, Spontaneous 
Precipitation, Ouzo Effect
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Solvent Displacement
• Polymer and drug are dissolved in a water-miscible 
organic solvent
• This solution is added to an aqueous solution
• Rapid solvent diffusion leads to instantaneous 
nanoparticle formation
• Solvent is removed by evaporation
Solvent Displacement
• Advantages
– Relatively simple process
– Nontoxic solvents can be used
– Does not require high shear stress
– Does not require surfactants or stabilizers
• Disadvantages
– Solvent evaporation can be time consuming
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The Importance of Size
• Nanoparticle Size
– Endothelial Permeability
• Particle escape from vasculature
– Liver sinus endothelium (up to 150 nm)





– Particle Degradation and Drug Release Rates
Ouzo Effect
• Solvent displacement is also referred to as the Ouzo 
effect
– Ouzo is a mixture of anethol, ethanol, and water (from 
anis seeds)
– Additional water leads to micro/nanoparticle formation 
– Solution proportions fall into a thermodynamically 
metastable region
• Homogeneous nucleation occurs 
• Leads to a uniform dispersion (milliseconds) followed by 
Ostwald ripening (seconds)
Ouzo Region
From Vitale and Katz, Langmuir 2003, 19, 4105-4110.
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4.0 mg/mL RG 502 H in acetone added to 0.1% Poloxamer.
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RG502H (RV = 1.19)
RG503H (RV = 1.30)
RG504H (RV = 1.41)
Relative Viscosity
          Viscosity of 10 mg/mL polymer
RV = 
           Viscosity of acetone alone
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Poloxamer 188 NF (Pluronic F68)






















































Nanoparticles prepared with 10 µg Coumarin-6 per 10 mg RG502H in 1 mL acetone, Zave = 117 ± 3 nm.  Fluorescence 
Microscopy settings:  λex = 488 nm, λem = 515 nm.  Suspension of particles in water after washing in a Sephadex G-50 column.
